ArticlePloS one2025
Using pre-training and interaction modeling for ancestry-specific disease prediction using multiomics data from the UK Biobank.
Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- mzLearn as a data-driven LC/MS signal detection algorithm that enables pre-trained generative models for untargeted metabolomics.Communications chemistry · 2025Article
Corrections and comments
- Update of
Authors and funding
5 authors.
Funding
Abstract
Recent genome-wide association studies (GWAS) have uncovered the genetic basis of complex traits, but show an under-representation of non-European descent individuals, underscoring a critical gap in genetic research. Prediction models trained primarily on European ancestry often fail to generalize to diverse populations, leading to reduced accuracy and potential health disparities. Here, we assess whether incorporating interaction modeling and pretraining into disease prediction models can improve performance. We evaluated the performance of Group-LASSO INTERaction-NET (glinternet) and pretrained lasso in disease prediction focusing on diverse ancestries in the UK Biobank. Models were trained on multiomic data from White British and other ancestries and validated in a cohort of more than 96,000 individuals for 8 diseases. Of the 96 trained models, we report 16 with statistically significant incremental predictive performance in terms of ROC-AUC scores ([Formula: see text]), found for diabetes, arthritis, gall stones, cystitis, asthma, and osteoarthritis. Our findings suggest that interaction terms and pre-training can modestly improve prediction accuracy, but these effects are not consistent across all diseases. Our code is available at (https://github.com/rivas-lab/AncestryOmicsUKB).
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.